查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1288895

全球细胞和基因治疗制造服务市场研究报告 - 行业分析、规模、份额、增长、趋势和2023年至2030年预测

Global Cell & Gene Therapy Manufacturing Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 250 Pages | 商品交期: 最快1-2个工作天内

价格

细胞和基因治疗制造服务包括细胞和基因治疗产品的全面和无缝制造和质量测试服务。该服务提供商帮助生物技术和制药公司以及研究团体促进转化和临床发现，并促进合作和创新的环境。细胞治疗制造服务包括异体、自体和病毒载体，而基因治疗制造服务包括非病毒载体、寡核苷酸和病毒载体。细胞和基因治疗制造服务提供了灵活和开创性的工具，以简化工作流程、创新、可扩展性、定制化、一致性、可重复性、减少风险，并在制造过程的每一步进行导航。

市场动态：

癌症和慢性病的高发率、制药和生物研究支出的增加以及公司和CDMO之间合作的增加等因素，主要推动了全球细胞和基因治疗制造服务市场的增长。细胞和基因疗法为治疗和缓解威胁生命的疾病提供了潜在的希望。制药公司正在大量投资于新药和疗法的开发。制药公司通常将其研究外包给CDMO或CRO，以专注于核心活动。此外，制药公司发现以高质量和高效率进行研发是一种挑战。对他们来说，外包是最好的方法。然而，与细胞和基因治疗制造有关的高运营成本可能会在一定程度上限制市场增长。

该研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于获得一个清晰的行业结构图，并在全球范围内评估竞争吸引力。此外，这些工具还对全球细胞和基因治疗制造服务市场的每个细分市场进行了全面评估。细胞和基因治疗制造服务行业的增长和趋势为这项研究提供了一个全面的方法。

区域分析：

本节涵盖了区域前景，强调了北美、欧洲、亚太、拉美、中东和非洲的细胞和基因治疗制造服务市场的当前和未来需求。此外，该报告重点关注所有突出地区的个别应用部门的需求、估计和预测。

该研究报告还涵盖了市场中主要参与者的全面概况和对全球竞争格局的深入看法。细胞和基因治疗制造服务市场的主要参与者包括Lonza（瑞士）、Catalent Inc.（美国）、Thermo Fisher Scientific Inc.（美国）、Charles River Laboratories（美国）、WuXi AppTec（中国）、Merck KGaA（德国）、Takara Bio Inc.(日本）、牛津生物医学公司（英国）、细胞和基因治疗中心（英国）、Genezen（美国）、FUJIFILM控股公司（日本）、尼康公司（日本）、The Discovery Labs LLC（美国）、RoslinCT（苏格兰）、JRS Pharma（德国）、FinVector（芬兰）、ABL Inc.(美国）、Resilience（美国）、BioCentriq（美国）、Porton Advanced Solutions（中国）、Andelyn Biosciences（美国）、Forge Biologics（美国）、Vibalogics（美国）、Anemocyte Srl（意大利）、ElevateBio（美国） 本节由竞争格局的整体观点组成，包括各种战略发展，如关键的合并和收购、未来能力、伙伴关系、财务概况、合作、新产品开发、新产品推出和其他发展。

  • 如果你有任何定制要求，请写信给我们。我们的研究团队可以根据您的需要提供定制报告。

目录

第1章：前言

  • 报告描述
    • 目的
    • 目标受众
    • 独特的销售主张（USP）和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法

第二章：执行摘要

  • 市场的亮点
  • 全球市场简介

第三章：细胞和基因治疗制造服务 - 行业分析

  • 简介 - 市场动态
  • 市场驱动力
  • 市场限制因素
  • 机会
  • 行业趋势
  • 波特的五力分析
  • 市场吸引力分析
    • 按类型
    • 按适应症分类
    • 按应用分类：按应用分类
    • 按终端用户
    • 按地区

第四章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原材料制造商名单
    • 关键原材料的价格趋势
  • 潜在买家名单
  • 营销渠道
    • 直接营销
    • 间接营销
    • 营销渠道的发展趋势

第五章：Covid-19爆发的影响分析

第六章：全球细胞和基因治疗制造服务市场分析：按类型划分

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 细胞治疗市场：按地区划分
  • 基因治疗市场：按地区划分

第7章 ：全球细胞和基因治疗制造服务市场分析：按适应症分类

  • 按适应症概述
  • 历史和预测数据
  • 按适应症分析
  • 肿瘤疾病市场：按地区划分
  • 心血管疾病市场：按地区划分
  • 骨科疾病市场：按地区划分
  • 眼科疾病市场：按地区划分
  • 中枢神经系统疾病市场：按地区划分
  • 传染性疾病市场：按地区划分
  • 其他市场：按地区划分

第八章：全球细胞和基因治疗制造服务市场分析：按应用分类

  • 概述：按应用分类
  • 历史和预测数据
  • 分析：按应用分类
  • 临床制造市场：按地区划分
  • 商业制造市场：按地区划分

第九章：全球细胞和基因治疗制造服务市场分析：按终端用户分类

  • 按终端用户概述
  • 历史和预测数据
  • 按终端用户分析
  • 制药和生物技术公司市场：按地区划分
  • 学术和研究机构市场：按地区划分
  • 其他终端用户市场：按地区划分

第十章：全球细胞和基因治疗制造服务市场分析：按地域划分

  • 区域展望
  • 简介
  • 北美洲
    • 概述、历史和预测数据
    • 北美洲：按细分市场划分
    • 北美洲：按国家划分
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 概述、历史和预测数据
    • 按部门分類的欧洲
    • 欧洲：按国家划分
    • 英国
    • 法国
    • 德国
    • 意大利
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 概述、历史和预测数据
    • 亚太地区按细分市场划分
    • 亚太地区：按国家划分
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
    • 亚太其他地区
  • 拉美地区
    • 概述、历史和预测数据
    • 按部门分類的拉美地区
    • 拉丁美洲：按国家划分
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 拉美其他地区
  • 中东和非洲
    • 概述、历史和预测数据
    • 中东和非洲，按细分市场划分
    • 中东和非洲：按国家分类
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 南非
    • 其他中东和非洲国家

第11章 ：细胞和基因治疗制造服务企业的竞争格局

  • 细胞和基因治疗制造服务市场竞争
  • 伙伴关系/合作/协议
  • 合併和收购
  • 新产品发布
  • 其他方面的发展

第十二章 ：公司简介

  • 公司份额分析
  • 市场集中度
  • Lonza (Switzerland)
    • 公司概况
    • 产品
    • 近期发展情况
  • Catalent Inc. (US)
    • 公司概况
    • 产品
    • 近期发展
  • Thermo Fisher Scientific Inc. (US)
    • 公司概况
    • 产品
    • 近期发展
  • Charles River Laboratories (US)
    • 公司概况
    • 产品
    • 近期发展
  • WuXi AppTec (China)
    • 公司概况
    • 产品
    • 近期发展
  • Merck KGaA (Germany)
    • 公司概况
    • 产品
    • 近期发展
  • Takara Bio Inc. (Japan)
    • 公司概况
    • 产品
    • 近期发展
  • Oxford Biomedica (UK)
    • 公司概况
    • 产品
    • 近期发展
  • Cell and Gene Therapy Catapult (UK)
    • 公司概况
    • 产品
    • 近期发展
  • Genezen (US)
    • 公司概况
    • 产品
    • 近期发展
  • FUJIFILM Holdings Corporation (Japan)
    • 公司概况
    • 产品
    • 近期发展
  • Nikon Corporation (Japan)
    • 公司概况
    • 产品
    • 近期发展
  • The Discovery Labs LLC (US)
    • 公司概况
    • 产品
    • 近期发展
  • RoslinCT (Scotland)
    • 公司概况
    • 产品
    • 近期发展
  • JRS Pharma (Germany)
    • 公司概况
    • 产品
    • 近期发展
  • FinVector (Finland)
    • 公司概况
    • 产品
    • 近期发展
  • ABL Inc. (US)
    • 公司概况
    • 产品
    • 近期发展
  • Resilience (US)
    • 公司概况
    • 产品
    • 近期发展
  • BioCentriq (US)
    • 公司概况
    • 产品
    • 近期发展
  • Porton Advanced Solutions (China)
    • 公司概况
    • 产品
    • 近期发展
  • Andelyn Biosciences (US)
    • 公司概况
    • 产品
    • 近期发展
  • Forge Biologics (US)
    • 公司概况
    • 产品
    • 近期发展
  • Vibalogics (US)
    • 公司概况
    • 产品
    • 近期发展
  • Anemocyte Srl (Italy)
    • 公司概况
    • 产品
    • 近期发展
  • ElevateBio (US)
    • 公司概况
    • 产品
    • 近期发展情况

注意 - 在公司简介中，财务细节和最近的发展情况要视情况而定，如果是私营公司，可能不包括在内。

Product Code: VMR11215654

Cell & gene therapy manufacturing services include comprehensive and seamless manufacturing and quality-testing services for cellular and gene therapy products. The service provider helps biotechnology & pharmaceutical companies and research groups boost translational and clinical discoveries and foster an environment of collaboration and innovation. Cell therapy manufacturing services include allogeneic, autologous, and viral vectors, while gene therapy manufacturing services non-viral vectors, oligonucleotides, and viral vectors. Cell & gene therapy manufacturing services provide flexible and pioneering tools to simplify workflow, innovation, scalability, customization, consistency, reproducibility, reducing risk, and navigate at every step of the manufacturing process.

Market Dynamics:

Factors such as the high prevalence of cancer and chronic diseases, increasing spending in pharmaceutical & biological research, and increasing collaboration among companies and CDMOs are primarily driving the growth of the global cell & gene therapy manufacturing services market. Cell and gene therapies offer potential promise to treat and relieve life-threatening diseases. Pharmaceutical companies are massively investing in the development of new drugs and therapies. Pharmaceutical companies are more usually outsource their research CDMOs or CROs to focus on core activities. Moreover, Pharmaceutical companies find it challenging to do R&D with high quality and efficiency. Outsourcing stands out as the best approach to them. However, the high operational costs concerned with cell & gene therapy manufacturing are likely to restrain market growth to some extent.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell & gene therapy manufacturing services. The growth and trends of cell & gene therapy manufacturing services industry provide a holistic approach to this study.

Market Segmentation:

This section of the cell & gene therapy manufacturing services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Cell Therapy (Allogeneic, Autologous, Viral Vector)
  • Gene Therapy (Non-viral Vector, Viral Vector)

By Indication

  • Oncology Diseases
  • Cardiovascular Diseases
  • Orthopedic Diseases
  • Ophthalmology Diseases
  • Central Nervous System Disorders
  • Infectious Diseases
  • Other

By Application

  • Clinical Manufacturing
  • Commercial Manufacturing

By End User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Other End User

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Cell & Gene Therapy Manufacturing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cell & gene therapy manufacturing services market include Lonza (Switzerland), Catalent Inc. (US), Thermo Fisher Scientific Inc. (US), Charles River Laboratories (US), WuXi AppTec (China), Merck KGaA (Germany), Takara Bio Inc. (Japan), Oxford Biomedica (UK), Cell and Gene Therapy Catapult (UK), Genezen (US), FUJIFILM Holdings Corporation (Japan), Nikon Corporation (Japan), The Discovery Labs LLC (US), RoslinCT (Scotland), JRS Pharma (Germany), FinVector (Finland), ABL Inc. (US), Resilience (US), BioCentriq (US), Porton Advanced Solutions (China), Andelyn Biosciences (US), Forge Biologics (US), Vibalogics (US), Anemocyte Srl (Italy), ElevateBio (US) This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

  • In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CELL & GENE THERAPY MANUFACTURING SERVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 By Type
    • 3.7.2 By Indication
    • 3.7.3 By Application
    • 3.7.4 By End User
    • 3.7.5 By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET ANALYSIS BY TYPE

  • 6.1 Overview by Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type
  • 6.4 Cell Therapy Market by Regions
  • 6.5 Gene Therapy Market by Regions

7 . GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET ANALYSIS BY INDICATION

  • 7.1 Overview by Indication
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Indication
  • 7.4 Oncology Diseases Market by Regions
  • 7.5 Cardiovascular Diseases Market by Regions
  • 7.6 Orthopedic Diseases Market by Regions
  • 7.7 Ophthalmology Diseases Market by Regions
  • 7.8 Central Nervous System Disorders Market by Regions
  • 7.9 Infectious Diseases Market by Regions
  • 7.10. Other Market by Regions

8 . GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET ANALYSIS BY APPLICATION

  • 8.1 Overview by Application
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Application
  • 8.4 Clinical Manufacturing Market by Regions
  • 8.5 Commercial Manufacturing Market by Regions

9 . GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET ANALYSIS BY END USER

  • 9.1 Overview by End User
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End User
  • 9.4 Pharmaceutical & Biotechnology Companies Market by Regions
  • 9.5 Academic & Research Institutes Market by Regions
  • 9.6 Other End User Market by Regions

10 . GLOBAL CELL & GENE THERAPY MANUFACTURING SERVICES MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America
    • 10.3.1. Overview, Historic and Forecast Data
    • 10.3.2. North America By Segment
    • 10.3.3. North America By Country
    • 10.3.4. United State
    • 10.3.5. Canada
    • 10.3.6. Mexico
  • 10.4. Europe
    • 10.4.1. Overview, Historic and Forecast Data
    • 10.4.2. Europe by Segment
    • 10.4.3. Europe by Country
    • 10.4.4. United Kingdom
    • 10.4.5. France
    • 10.4.6. Germany
    • 10.4.7. Italy
    • 10.4.8. Russia
    • 10.4.9. Rest Of Europe
  • 10.5. Asia Pacific
    • 10.5.1. Overview, Historic and Forecast Data
    • 10.5.2. Asia Pacific by Segment
    • 10.5.3. Asia Pacific by Country
    • 10.5.4. China
    • 10.5.5. India
    • 10.5.6. Japan
    • 10.5.7. South Korea
    • 10.5.8. Australia
    • 10.5.9. Rest Of Asia Pacific
  • 10.6. Latin America
    • 10.6.1. Overview, Historic and Forecast Data
    • 10.6.2. Latin America by Segment
    • 10.6.3. Latin America by Country
    • 10.6.4. Brazil
    • 10.6.5. Argentina
    • 10.6.6. Peru
    • 10.6.7. Chile
    • 10.6.8. Rest of Latin America
  • 10.7. Middle East & Africa
    • 10.7.1. Overview, Historic and Forecast Data
    • 10.7.2. Middle East & Africa by Segment
    • 10.7.3. Middle East & Africa by Country
    • 10.7.4. Saudi Arabia
    • 10.7.5. UAE
    • 10.7.6. Israel
    • 10.7.7. South Africa
    • 10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE CELL & GENE THERAPY MANUFACTURING SERVICES COMPANIES

  • 11.1. Cell & Gene Therapy Manufacturing Services Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF CELL & GENE THERAPY MANUFACTURING SERVICES INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Lonza (Switzerland)
    • 12.3.1. Company Overview
    • 12.3.2. Financials
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Catalent Inc. (US)
    • 12.4.1. Company Overview
    • 12.4.2. Financials
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Thermo Fisher Scientific Inc. (US)
    • 12.5.1. Company Overview
    • 12.5.2. Financials
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Charles River Laboratories (US)
    • 12.6.1. Company Overview
    • 12.6.2. Financials
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. WuXi AppTec (China)
    • 12.7.1. Company Overview
    • 12.7.2. Financials
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. Merck KGaA (Germany)
    • 12.8.1. Company Overview
    • 12.8.2. Financials
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. Takara Bio Inc. (Japan)
    • 12.9.1. Company Overview
    • 12.9.2. Financials
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Oxford Biomedica (UK)
    • 12.10.1. Company Overview
    • 12.10.2. Financials
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Cell and Gene Therapy Catapult (UK)
    • 12.11.1. Company Overview
    • 12.11.2. Financials
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Genezen (US)
    • 12.12.1. Company Overview
    • 12.12.2. Financials
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. FUJIFILM Holdings Corporation (Japan)
    • 12.13.1. Company Overview
    • 12.13.2. Financials
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. Nikon Corporation (Japan)
    • 12.14.1. Company Overview
    • 12.14.2. Financials
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. The Discovery Labs LLC (US)
    • 12.15.1. Company Overview
    • 12.15.2. Financials
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. RoslinCT (Scotland)
    • 12.16.1. Company Overview
    • 12.16.2. Financials
    • 12.16.3. Products
    • 12.16.4. Recent Developments
  • 12.17. JRS Pharma (Germany)
    • 12.17.1. Company Overview
    • 12.17.2. Financials
    • 12.17.3. Products
    • 12.17.4. Recent Developments
  • 12.18. FinVector (Finland)
    • 12.18.1. Company Overview
    • 12.18.2. Financials
    • 12.18.3. Products
    • 12.18.4. Recent Developments
  • 12.19. ABL Inc. (US)
    • 12.19.1. Company Overview
    • 12.19.2. Financials
    • 12.19.3. Products
    • 12.19.4. Recent Developments
  • 12.20. Resilience (US)
    • 12.20.1. Company Overview
    • 12.20.2. Financials
    • 12.20.3. Products
    • 12.20.4. Recent Developments
  • 12.21. BioCentriq (US)
    • 12.21.1. Company Overview
    • 12.21.2. Financials
    • 12.21.3. Products
    • 12.21.4. Recent Developments
  • 12.22. Porton Advanced Solutions (China)
    • 12.22.1. Company Overview
    • 12.22.2. Financials
    • 12.22.3. Products
    • 12.22.4. Recent Developments
  • 12.23. Andelyn Biosciences (US)
    • 12.23.1. Company Overview
    • 12.23.2. Financials
    • 12.23.3. Products
    • 12.23.4. Recent Developments
  • 12.24. Forge Biologics (US)
    • 12.24.1. Company Overview
    • 12.24.2. Financials
    • 12.24.3. Products
    • 12.24.4. Recent Developments
  • 12.25. Vibalogics (US)
    • 12.25.1. Company Overview
    • 12.25.2. Financials
    • 12.25.3. Products
    • 12.25.4. Recent Developments
  • 12.26. Anemocyte Srl (Italy)
    • 12.26.1. Company Overview
    • 12.26.2. Financials
    • 12.26.3. Products
    • 12.26.4. Recent Developments
  • 12.27. ElevateBio (US)
    • 12.27.1. Company Overview
    • 12.27.2. Financials
    • 12.27.3. Products
    • 12.27.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Cell Therapy Market by Geography (USD MN)
  • Gene Therapy Market by Geography (USD MN)
  • Analysis Market by Indication (USD MN)
  • Oncology Diseases Market by Geography (USD MN)
  • Cardiovascular Diseases Market by Geography (USD MN)
  • Orthopedic Diseases Market by Geography (USD MN)
  • Ophthalmology Diseases Market by Geography (USD MN)
  • Central Nervous System Disorders Market by Geography (USD MN)
  • Infectious Diseases Market by Geography (USD MN)
  • Other Market by Geography (USD MN)
  • Analysis by Application (USD MN)
  • Clinical Manufacturing Market by Geography (USD MN)
  • Commercial Manufacturing Market by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Pharmaceutical & Biotechnology Companies Market by Geography (USD MN)
  • Academic & Research Institutes Market by Geography (USD MN)
  • Other End User Market by Geography (USD MN)
  • Global Cell & Gene Therapy Manufacturing Services Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton

LIST OF FIGURES

  • Research Scope of Cell & Gene Therapy Manufacturing Services Report
  • Market Research Process
  • Market Research Methodology
  • Global Cell & Gene Therapy Manufacturing Services Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Cell Therapy Market by Geography (USD MN)
  • Gene Therapy Market by Geography (USD MN)
  • Global Market Analysis by Indication (USD MN)
  • Oncology Diseases Market by Geography (USD MN)
  • Cardiovascular Diseases Market by Geography (USD MN)
  • Orthopedic Diseases Market by Geography (USD MN)
  • Ophthalmology Diseases Market by Geography (USD MN)
  • Central Nervous System Disorders Market by Geography (USD MN)
  • Infectious Diseases Market by Geography (USD MN)
  • Other Market by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Clinical Manufacturing Market by Geography (USD MN)
  • Commercial Manufacturing Market by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Pharmaceutical & Biotechnology Companies Market by Geography (USD MN)
  • Academic & Research Institutes Market by Geography (USD MN)
  • Other End User Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.